gefitinib has been researched along with tocophersolan in 1 studies
Studies (gefitinib) | Trials (gefitinib) | Recent Studies (post-2010) (gefitinib) | Studies (tocophersolan) | Trials (tocophersolan) | Recent Studies (post-2010) (tocophersolan) |
---|---|---|---|---|---|
5,231 | 566 | 2,919 | 578 | 10 | 469 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (100.00) | 2.80 |
Authors | Studies |
---|---|
Alanazi, FK; Ali, EA; Alqahtani, AS; Attia, SM; Harisa, GI; Nasr, FA; Omran, GA; Sherif, AY | 1 |
1 other study(ies) available for gefitinib and tocophersolan
Article | Year |
---|---|
TPGS decorated NLC shift gefitinib from portal absorption into lymphatic delivery: Intracellular trafficking, biodistribution and bioavailability studies.
Topics: Biological Availability; Chylomicrons; Drug Carriers; Gefitinib; Male; Nanoparticles; Particle Size; Rats; Tissue Distribution | 2023 |